Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002125506 | SCV002449568 | likely benign | Familial aplasia of the vermis; Meckel-Gruber syndrome | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002500203 | SCV002801876 | likely benign | COACH syndrome 1; Joubert syndrome 6; Meckel syndrome, type 3; RHYNS syndrome; Bardet-Biedl syndrome 14; Nephronophthisis 11 | 2021-07-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003070584 | SCV003554999 | likely benign | Inborn genetic diseases | 2022-03-28 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV004543868 | SCV004796104 | likely benign | TMEM67-related disorder | 2019-03-18 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |